Herborium Group, Inc. (HBRM)

Intra-Cellular Therapies Cash Flow Statement

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Aug 31, 2012	Nov 30, 2011	Nov 30, 2010	Nov 30, 2009	Nov 30, 2008	Nov 30, 2007
Net Income	-	-0.25	-0.58	-0.94	-0.9	-0.64
Depreciation & Amortization	-	0.01	0.02	0.05	0.1	0
Stock-Based Compensation	-	0.08	0.36	0.58	0.34	0.22
Other Operating Activities	-	-0.01	0.03	-	0	-
Change in Accounts Receivable	-	-0	-0	-	0	0
Change in Inventory	-	0	0.01	-0	-0.01	0.04
Change in Accounts Payable	-	0.2	0.18	0.26	0.16	0.29
Change in Other Net Operating Assets	-	-	-	-	0.01	-
Operating Cash Flow	-	0.04	0.01	-0.06	-0.29	-0.09
Operating Cash Flow Growth	-	213.24%	-	-	-	-
Capital Expenditures	-	-	-	-	-0.01	-
Sale (Purchase) of Intangibles	-	-	-	-0	-0.07	-0
Investing Cash Flow	-	-	-	-0	-0.08	-0
Short-Term Debt Issued	-	0.03	0.05	-	0.04	0.07
Long-Term Debt Issued	-	-	-	-	0.44	0.03
Total Debt Issued	-	0.03	0.05	-	0.48	0.1
Short-Term Debt Repaid	-	-0.03	-0.1	-0.08	-0.11	-0.01
Total Debt Repaid	-	-0.03	-0.1	-0.08	-0.11	-0.01
Net Debt Issued (Repaid)	-	-0	-0.06	-0.08	0.37	0.09
Issuance of Common Stock	-	0.05	0.07	0.15	-	-
Other Financing Activities	-	-	-	-0	-	-
Financing Cash Flow	-	0.04	0.02	0.06	0.37	0.09
Miscellaneous Cash Flow Adjustments	-	-0.08	-0.03	-	-	-
Net Cash Flow	-	0	0	-	-0	-0
Free Cash Flow	-	0.04	0.01	-0.06	-0.3	-0.09
Free Cash Flow Growth	-	213.24%	-	-	-	-
Free Cash Flow Margin	-	18.17%	5.19%	-27.19%	-73.22%	-11.29%
Free Cash Flow Per Share	-	0.13	0.05	-0.34	-2.11	-0.76
Cash Interest Paid	-	0.01	0.01	0.02	0.05	0.05
Cash Income Tax Paid	-	0	0	0	0	-
Levered Free Cash Flow	-	0.07	-0.2	0.26	-0.05	0.15
Unlevered Free Cash Flow	-	0.08	-0.17	0.32	0.01	0.18
Change in Net Working Capital	-	-0.14	0.19	-0.22	-0.14	-0.33

Source: S&P Global Market Intelligence. Standard template. Financial Sources.